Hemostasis of Left Atrial Appendage Bleed With Lariat Device

New devices designed for minimally invasive closure of the left atrial appendage (LAA) may be a viable alternative for patients in whom anticoagulation is considered high risk. The Lariat (Sentreheart, Redwood City, CA), which is currently FDA-approved for percutaneous closure of tissue, requires bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Amena, Saric, Muhamed, Bernstein, Scott, Holmes, Douglas, Chinitz, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Indian Heart Rhythm Society 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217304/
https://www.ncbi.nlm.nih.gov/pubmed/25408569
Descripción
Sumario:New devices designed for minimally invasive closure of the left atrial appendage (LAA) may be a viable alternative for patients in whom anticoagulation is considered high risk. The Lariat (Sentreheart, Redwood City, CA), which is currently FDA-approved for percutaneous closure of tissue, requires both trans-septal puncture and epicardial access. However it requires no anticoagulation after the procedure. Here we describe a case of effusion and tamponade during a Lariat procedure with successful completion of the case and resolution of the effusion.

Ejemplares similares